1、12026 CVS Health and/or one of its affiliates.Confidential and proprietary.Fourth Quarter 2025 February 10,2026J.David JoynerChair andChief Executive OfficerBrian O.NewmanExecutive Vice President andChief Financial OfficerEarnings Conference Call 22026 CVS Health and/or one of its affiliates.Confide
2、ntial and proprietary.Cautionary Statementconcerning forward-looking statementsThis presentation includes forward-looking statements.The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of CVS Health Corporation(“CVS Health”)
3、.By their nature,all forward-looking statements are not guarantees of future performance or results and are subject to risks and uncertainties that are difficult to predict and/or quantify.Actual results may also differ materially from those contemplated by the forward-looking statements due to the
4、risks and uncertainties described in our Securities and Exchange Commission filings,including those set forth in the Risk Factors section and under the heading“Cautionary Statement Concerning Forward-Looking Statements”in our most recent Annual Report on Form 10-K,our recent Current Reports on Form
5、8-K and this mornings earnings press release.This presentation includes non-GAAP financial measures that we use to describe our companys performance.In accordance with SEC regulations,you can find the definitions of these non-GAAP measures,as well as reconciliations to the most directly comparable G
6、AAP measures,in our press release we issued in connection with the release of our results for the fourth quarter of 2025 and our non-GAAP reconciliation document,which are both available on the Investor Relations portion of our website.32026 CVS Health and/or one of its affiliates.Confidential and p